--:--:--

Gufic Biosciences Limited

Web: gufic.com NSE: GUFICBIO BSE: 509079 SECTOR: Healthcare - Pharmaceuticals & Biotechnology | Add Note | View Notes

388 16(-4%)

Volume

1L as on 23, Jun

Open

431

High

437

Low

428

Close

404

VWAP

368

52 Week High

468

52 Week Low

268

Viand Research Rating
Quality Score

51/100

Growth Score

32/100

Valuation Score

50/100

Momentum Score

45/100

Analyst Recommendations

BUY/SELL

Hold | Buy | Strong Buy
Analyst Price Target
-
Market Cap (cr)

3,891

No. of Shares

10

P/E

49.02

P/B

7.82

Face Value

1

Div. Yield

-

Book Value (TTM)

-

CASH

-

DEBT

-

EPS (TTM)

-

ROE

15.95

ROCE

-

Profit Growth

-

Listing Date

19-Oct-04

Rank/Sector Rank

#941/#85

Promoter Holding

72.5%

FII Holding

0.47%

DII Holding

3.67%

Price Chart
Price Performance
1 Week0%
1 Month26%
3 Months32%
6 Months28%
1 Year28%
YTD28%
Moving Average
5 Day SMA362
10 Day SMA363
20 Day SMA358
30 Day SMA335
50 Day SMA320
61 Day SMA314
80 Day SMA0
200 Day SMA0
PIVOT LEVEL
StandardCamarillaFibonacciWoodie's
Resistance 3379364373378
Resistance 2373363369373
Resistance 1367362366366
Pivot Point361360361361
Support 1355359356354
Support 2349358353348
Support 3342357349342
Competitors/Peers
#SymbolMCAPLTP1W1M6M1YP/EInd PEDebt/EqNP Qtr Rs.Cr.
1SUNPHARMA4,18,69817450%5%4%4%3755.50.0711509
2DIVISLAB2,43,96691902%0%45%38%6955.502568
3TORNTPHARM1,73,20845542%5%10%28%7255.51.792138
4ZYDUSLIFE1,11,45111170%1%20%12%2055.50.313560
5APOLLOHOSP1,09,27676002%9%4%1%5855.50.92003
6LAURUSLABS1,08,73820121%8%83%124%055.50.48890
7CIPLA1,06,15413142%2%8%19%2255.50.023862
8DRREDDY1,03,87312443%8%1%4%2055.50.24158
9MANKIND94,40122864%1%8%7%4955.50.391938
10AUROPHARMA90,84115792%1%20%52%055.50.192415
Load More
Shareholding Pattern (%)
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022Dec 2021Sep 2021
Promoters(0.01) 72.50%(0.01) 72.50%(0.01) 72.50%(0.01) 72.50%(0.01) 72.51%(0.01) 72.51%(0.01) 72.51%(0.01) 72.51%(0.01) 72.51%(0.01) 72.51%(-2.51) 72.51%(0.01) 75.00%(0.01) 75.00%(0.01) 75.00%(0.01) 75.00%(0.01) 75.00%(-0.51) 75.00%(0.01) 75.48%(0.01) 75.48%(0.01) 75.48%
FIIs(0.11) 0.47%(0.01) 0.42%(0.11) 0.44%(0.01) 0.33%(0.01) 0.32%(0.01) 0.31%(0.11) 0.30%(0.01) 0.23%(0.11) 0.23%(-0.41) 0.12%(-0.31) 0.47%(0.01) 0.72%(0.01) 0.70%(0.61) 0.72%(0.11) 0.16%(-1.31) 0.06%(-0.11) 1.38%(-0.21) 1.51%(0.21) 1.69%(0.01) 1.52%
DIIs(-0.21) 3.67%(0.11) 3.83%(0.11) 3.74%(0.31) 3.66%(0.01) 3.38%(0.41) 3.39%(0.51) 2.99%(0.11) 2.51%(0.21) 2.38%(0.51) 2.20%(0.11) 1.72%(0.51) 1.63%(0.01) 1.16%(0.01) 1.16%(0.01) 1.16%(0.01) 1.16%(0.01) 1.13%(-0.11) 1.12%(-0.91) 1.19%(0.01) 2.13%
Public23.36%23.23%23.30%23.51%23.81%23.79%24.20%24.75%24.89%25.17%25.29%22.64%23.12%23.12%23.67%23.76%22.49%21.89%21.64%20.87%
No. of Shareholders29,75329,22330,36231,42031,87631,84433,29932,82532,25034,69534,42436,55738,62438,90240,56241,37640,12038,14434,58035,135
Quarterly Results
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023
Sales261252231230227205208204203195202215195
Sales Growth % (YoY)14.9%22.9%11.2%12.8%11.9%5.1%3%-5%4%12.7%13.7%22.9%18%
Sales Growth % (QoQ)3.6%9.1%0.4%1.3%10.7%-1.4%2%0.5%4.1%-3.5%-6%10.3%-
Expenses214206195195195178174166167161165176160
Operating Profit47463636322734393634363935
OPM %18181616141316191818181818
Other Income0-112102011001
Interest99810985554344
Depreciation8888885444444
Profit before tax30282121161126292827303128
Tax %26262627262626262626252526
Net Profit 2221161512819222120222321
Net Profit Growth % (QoQ)4.8%31.2%6.7%25%50%-57.9%-13.6%4.8%5%-9.1%-4.3%9.5%-
Net Profit Growth % (YoY)83.3%162.5%-15.8%-31.8%-42.9%-60%-13.6%-4.3%-----
TTM Net Profit7464515461708285868666440
EPS in Rs2.242.051.551.491.20.791.932.172.0822.222.392.13
Profit and Loss
Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015
Sales940820807691779488379351306245201148
Sales Growth %14.7%1.6%16.8%-11.4%59.8%28.7%8%14.8%24.6%22%35.9%22.5%
Expenses790683657556631404327305267222181134
Operating Profit15013615013514884524639232014
OPM %16171920191714131391010
Other Income340334644111
Interest372517851414109664
Depreciation3121172219161454444
Profit before tax85941161071275830353014107
Tax %262626252423253845372936
Net Profit 637086809644232216974
Net Profit Growth %-10%-18.6%7.5%-16.7%118.2%91.3%4.5%37.5%77.8%28.6%75%-
EPS in Rs6.36.978.598.229.895.682.922.822.131.170.950.54
Dividend Payout %211112222459
Cash Flows
Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015
Cash from Operating Activity44123-7-2710687475-5-4-411
Cash from Investing Activity-31-72-102-191-95-7-43-13-9-5-1-2
Cash from Financing Activity32-3782234-6-79-481475-5
Net Cash Flow4514-271752001-104
Balance Sheet
Mar 2026Sep 2025Mar 2025Sep 2024Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015
Equity Capital10101010101010101088888
Reserves6546215915645233382591641206846302619
Borrowings40536933629633333464621269880574333
Other Liabilities273271232235227179188157152106104847567
Total Liabilities13421271117011051093861521392408280238178152127
Fixed Assets491495506149159160115100832423222225
CWIP222422363307170411331102000
Investments32322100000000
Other Assets826750639590625531365279294245213156130102
Total Assets13421271117011051093861521392408280238178152127
Delivery

Delivery Data: GUFICBIO

#Date
377
24%
468
Value (Cr)Q/T
21		Del
48		Del
5
121-Oct390
10
22495
219-Oct404
3
15451
316-Oct404
1
17631
415-Oct408
1
16320
514-Oct417
2
19561
613-Oct412
4
11582
712-Oct419
4
30602
89-Oct406
3
21501
98-Oct404
3
20562
107-Oct423
2
19591
116-Oct428
3
19471
125-Oct420
3
11481
131-Oct418
9
20414
1430-Sep432
7
29443
1529-Sep436
6
20463
1628-Sep420
2
20531
1725-Sep424
1
14511
1824-Sep422
3
22572
1923-Sep437
4
31632
2022-Sep442
3
25672
2121-Sep436
3
15481
2218-Sep436
3
19471
2317-Sep426
1
18641
2416-Sep420
5
24663
2515-Sep425
3
20612
2611-Sep425
4
24532
2710-Sep423
3
20521
289-Sep429
3
18502
298-Sep440
3
21491
307-Sep448
17
31427
314-Sep445
4
25512
323-Sep439
5
19442
332-Sep439
31
30309
341-Sep421
4
18472
3531-Aug416
7
22393
3628-Aug406
3
25501
3727-Aug412
2
22551
3826-Aug408
2
24621
3925-Aug414
2
18551
4024-Aug418
4
25532
4121-Aug432
9
28454
4220-Aug414
3
20522
4319-Aug422
3
16511
4418-Aug421
5
22462
4517-Aug418
12
23375
4614-Aug422
7
26584
4713-Aug430
3
17512
4812-Aug425
5
22482
Daily Market Cap
DateTotal Market CapChangeChg %
21-Oct3,891c161c3.96
19-Oct4,051c20c0.50
17-Oct4,031c00
16-Oct4,031c100c2.43
15-Oct4,132c12c0.29
14-Oct4,120c37c0.91
13-Oct4,083c102c2.43
12-Oct4,184c143c3.55
09-Oct4,041c41c1.00
08-Oct4,082c135c3.20
05-Oct4,216c36c0.85
01-Oct4,181c108c2.51
29-Sep4,289c57c1.35
28-Sep4,231c15c0.36
25-Sep4,216c119c2.75
24-Sep4,336c98c2.21
22-Sep4,434c196c4.61
17-Sep4,238c14c0.33
10-Sep4,252c252c5.60
07-Sep4,504c96c2.18
04-Sep4,408c00
Stock Checklist
Price is above from 52 week high low average: 60%
Stock is trading above all short term SMAs: NO
Stock is trading above all long term SMAs: YES
Stock is Consistently Improving Long Term: NO
FII purchased in last quarter: YES
Promoters are buying the stock: NO
Mutual Fund Holdings

Held by 18 fund scheme(s) across 5 fund house(s) as of Oct26 · Total value ₹261 Cr · 6 increasing / 2 decreasing · View in MF Pro →

Fund HouseSchemesWeight %ChangeValue (Cr)
ICICI Prudential Mutual Fund60.21%+0.03%142
Bank of India Mutual Fund60.83%-0.01%83.9
SBI Mutual Fund20.29%-34.6
Bandhan Mutual Fund20.05%-0
Motilal Oswal Mutual Fund20.00%-0
Strategy Builder
Bulk Deals
Events
News
Exchange Filings
Annual Reports
Ratings & Research Reports
Concalls
Announcements
For research & education only — not investment advice. Not a SEBI-registered Investment Adviser or Research Analyst. Data may be delayed or inaccurate. Investments in securities markets are subject to market risks.
0